Cardiac involvement in non-cirrhotic portal hypertension: MRI detects myocardial fibrosis and oedema similar to compensated cirrhosis

Eur Heart J Cardiovasc Imaging. 2023 Jun 21;24(7):949-960. doi: 10.1093/ehjci/jeac235.

Abstract

Aims: The exact role of portal hypertension in cirrhotic cardiomyopathy remains unclear, and it is uncertain whether cardiac abnormalities also occur in non-cirrhotic portal hypertension (NCPH). This magnetic resonance imaging (MRI) study aimed to evaluate the presence of subclinical myocardial dysfunction, oedema, and fibrosis in NCPH.

Methods and results: In this prospective study (2018-2022), participants underwent multiparametric abdominal and cardiac MRI including assessment of cardiac function, myocardial oedema, late gadolinium enhancement (LGE), and abdominal and cardiac mapping [T1 and T2 relaxation times, extracellular volume fraction (ECV)]. A total of 111 participants were included [44 participants with NCPH (48 ± 15 years; 23 women), 47 cirrhotic controls, and 20 healthy controls]. The cirrhotic group was dichotomized (Child A vs. Child B/C). NCPH participants demonstrated a more hyperdynamic circulation compared with healthy controls (cardiac index: 3.7 ± 0.6 vs. 3.2 ± 0.8 L/min/m², P = 0.004; global longitudinal strain: -27.3 ± 4.6 vs. -24.6 ± 3.5%, P = 0.022). The extent of abnormalities indicating myocardial fibrosis and oedema in NCPH was comparable with Child A cirrhosis (e.g. LGE presence: 32 vs. 33 vs. 69%, P = 0.004; combined T1 and T2 elevations: 46 vs. 27 vs. 69%, P = 0.017; NCPH vs. Child A vs. Child B/C). Correlations between splenic T1 and myocardial T1 values were found (r = 0.41; P = 0.007). Splenic T1 values were associated with the presence of LGE (odds ratio, 1.010; 95% CI: 1.002, 1.019; P = 0.013).

Conclusion: MRI parameters of myocardial fibrosis and oedema were altered in participants with NCPH to a similar extent as in compensated cirrhosis and were associated with splenic markers of portal hypertension, indicating specific portal hypertensive cardiomyopathy.

Keywords: cirrhotic cardiomyopathy; fibrosis; mapping; multiparametric cardiac magnetic resonance; non-cirrhotic portal hypertension; oedema.

MeSH terms

  • Cardiomyopathies* / diagnostic imaging
  • Cardiomyopathies* / etiology
  • Child
  • Contrast Media
  • Edema / diagnostic imaging
  • Edema / etiology
  • Edema / pathology
  • Female
  • Fibrosis
  • Gadolinium
  • Humans
  • Hypertension, Portal* / diagnostic imaging
  • Hypertension, Portal* / etiology
  • Hypertension, Portal* / pathology
  • Magnetic Resonance Imaging / methods
  • Magnetic Resonance Imaging, Cine
  • Myocardium / pathology
  • Predictive Value of Tests
  • Prospective Studies

Substances

  • Contrast Media
  • Gadolinium